Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00169260 · ClinicalTrials.gov registry record · Phase 2
Proactive Health Intervention for Tobacco Users (Get PHIT)
A Phase 2 study of Smoking, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 2
- Development phase
- 536
- Enrollment target
- 1
- Study location
NCT00169260: Completed Phase 2 study of Smoking, sponsored by Kaiser Permanente.
NCT00169260 is a Phase 2 study of Smoking that has completed, run by Kaiser Permanente. The registered enrollment target is 536 participants, above the 451-participant average among 123 other Smoking trials with a reported enrollment target (19% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00169260, a Phase 2 study of Smoking, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 536 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to understand how information about smokers' health risks affects their attitudes, mood, and behavior.
Conditions Studied
Interventions
- BEHAVIORAL motivational counseling
- BEHAVIORAL placebo
Study Locations (1)
Washington
- Group Health Cooperative - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 536 participants |
| Start Date | 2005-02 |
| Est. Completion | 2010-02 |
| Phase | Phase 2 |
What the finished NCT00169260 record still lists
NCT00169260 is an interventional study that assigns participants to a tested intervention. The registered 536 participants enrollment target is mid-sized for trials with a published cap, above the 451-participant average among 123 other Smoking trials with a reported enrollment target (19% higher).
The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 2 interventions - of which motivational counseling is the first listed.
NCT00169260 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT00169260 about?
NCT00169260 is a clinical study titled "Proactive Health Intervention for Tobacco Users (Get PHIT)". The goal of this study is to understand how information about smokers' health risks affects their attitudes, mood, and behavior.
What is the current status of trial NCT00169260?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 536 participants. The study started on 2005-02. Estimated completion is 2010-02.
What conditions does trial NCT00169260 study?
This clinical trial studies the following conditions: Smoking.
What interventions are being tested in trial NCT00169260?
The interventions under investigation include: motivational counseling (BEHAVIORAL), placebo (BEHAVIORAL).
Who is sponsoring clinical trial NCT00169260?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00169260 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00169260's enrollment target sits among peer trials
536 29th of 123 higher than 95 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence
RECRUITING · Phase 2
-
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
RECRUITING · Phase 2
-
App for Reducing Cravings to Smoke
RECRUITING · Phase 2
-
Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava
ACTIVE NOT RECRUITING · Phase 2
-
Computer-Assisted Intervention for Smoking During Pregnancy
COMPLETED · Phase 2
-
Oxidative Stress and Vitamin E Requirements
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05880004 · 537 participants · NA
Developing a Support Application for Food Pantries (SAFPAS) to Improve Client Access to Healthy Foods & Enhance Emergency Preparedness
- NCT05614739 · 535 participants · Phase 1
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
- NCT07091617 · 535 participants · NA
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
- NCT03772028 · 538 participants · Phase 3
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia